moderna-and-novavax-stocks-are-tumbling-because-good-news-on-a-covid-pill-is-bad-news-for-vaccines

Moderna and Novavax Stocks Are Tumbling Because Good News on a Covid Pill Is Bad News for Vaccines

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/moderna-stock-novavax-covid-vaccine-51633107009


  • Order Reprints

  • Print Article

Vaccine manufacturer stocks slid on Friday after Merck announced its oral Covid-19 antiviral pill cut the risk of hospitalization or death by approximately 50%.

While Merck’s good news paves the way for turning the page on the pandemic, it fueled fears that demand for Covid-19 vaccines will decline in upcoming months, impacting vaccine manufacturers and biotech companies developing their own Covid-19 treatments.

Shares…